Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

It Is Cancer in Kate Middleton.

2.

For elderly, unfit patients, the all-oral AML regimen shows promise.

3.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

4.

Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

5.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot